Answers are grounded in this paper and cite their sources.
Contemporary gerontology has shifted from single-target pharmacological paradigms toward multi-hallmark frameworks for understanding biological aging. Yoga, encompassing asana, pranayama, and dhyana, has attracted scientific interest as a systems-level psychoneuroimmunological intervention. This review evaluates the molecular and cellular mechanisms through which Yogic practice exerts antiaging effects, situates Yoga within a comparative framework alongside aerobic exercise, caloric restriction, and established pharmacological agents, and delineates the most consequential gaps in the current evidence base. A narrative review of mechanistic, neuroimaging, psychoneuroimmunological, and clinical trial evidence was conducted. Published literature from PubMed, EMBASE, and Cochrane databases was reviewed, emphasizing randomized controlled trials, longitudinal cohort studies, and systematic reviews in populations aged 50 years and above. Yoga modulates multiple hallmarks of aging through its primary axis of action on the hypothalamic–pituitary–adrenal (HPA) axis and autonomic nervous system. Documented molecular effects include upregulation of telomerase reverse transcriptase and sirtuin-1, attenuation of age-related epigenetic drift as measured by epigenetic clocks, enhanced endogenous antioxidant enzyme activity, activation of the cholinergic anti-inflammatory pathway, induction of brain-derived neurotrophic factor, and preservation of hippocampal volume and cortical thickness. The comparative multi-hallmark profile of Yoga, particularly across the epigenetic, neuroendocrine, and cognitive-contemplative domains, is not replicated by any single pharmacological agent currently under clinical investigation. Yoga warrants reconceptualisation as a qualitatively distinct anti-aging intervention operating through psychoneuroimmunological and epigenetic pathways inaccessible to physical training or pharmacotherapy alone. Large-scale multi-omic randomized controlled trials in older Indian and global populations represent a high-priority research agenda for geriatric medicine.
No takes yet. Share an insight, caveat, or question.
Divya Sharma (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: